FOXO3 (forkhead box O3; HGNC:3821, NCBI Gene ID 2309) is a human locus mapped to chromosome band 6q21 that encodes winged-helix Forkhead Box O3 transcription factor (673 aa). FOXO3 acts in attenuated IIS (IGF1R-AKT1) & activated AMPK/SIRT1 -> nuclear induction of SOD2, CAT, GADD45A, autophagy (LC3/BNIP3) & stem-cell maintenance, together with FOXO1 (Metabolic Paralog Gene), FOXO4 (Senescence Paralog Gene), and IGF1R (Upstream Receptor Suppressing FOXO3). Encodes the Forkhead box O3 transcription factor whose intronic enhancer variants are among the most consistently replicated genetic determinants of human longevity.
Second most replicated human longevity gene across global centenarian cohorts (after APOE); preserves ovarian primordial follicle reserve
Gene Structure & Expression
Genomic Organization & Cytogenetic Locus: 4-exon gene (2 coding exons) spanning 125 kb on chromosome 6q21, harboring a cluster of longevity-associated intronic single-nucleotide polymorphisms (notably rs2802292 G-allele in intron 2, which creates a stress-inducible HSF1 heat-shock transcription factor chromatin looping enhancer) and encoding a 673-residue winged-helix transcription factor.
Cellular & Tissue Expression Profile: Ubiquitously expressed across adult stem cell niches (hematopoietic, neural, and skeletal muscle satellite stem cells), cardiac myocytes, skeletal muscle, vascular endothelium, cerebellar and cortical neurons, and ovarian primordial follicle oocytes.
Molecular Function & Pathways
Biochemical & Physiological Mechanism: Ortholog of the Caenorhabditis elegans longevity factor DAF-16: when growth factor signaling through IGF1R-PI3K-AKT1 is high, AKT1 phosphorylates FOXO3 at Thr32, Ser253, and Ser315 to sequester it in the cytoplasm bound to 14-3-3 proteins; during caloric restriction, fasting, or oxidative stress, AMPK phosphorylates FOXO3 (at Ser413/Ser588) and nuclear SIRT1/SIRT2 deacetylate it, driving FOXO3 into the nucleus (and mitochondria) to activate a comprehensive cytoprotective program—reactive oxygen species scavengers (SOD2, catalase, PRDX3), DNA repair (GADD45A, DDB1), macroautophagy and mitophagy (MAP1LC3B, BNIP3, ULK2), proteasomal proteostasis, and cell-cycle quiescence (p27Kip1 / CDKN1B, CCNG2).
Clinical & Therapeutic Significance
Human Genetic Variants & Disease Phenotypes: First discovered in the Hawaii Lifespan Study (Willcox et al., 2008) and subsequently replicated across >15 independent Japanese, European, Chinese, and Ashkenazi centenarian cohorts, homozygotes for the FOXO3 G-allele (rs2802292) have a 1.5- to 2.7-fold higher odds of reaching age 95–100+ with lower coronary heart disease mortality and preserved insulin sensitivity; in females, Foxo3 also acts as the molecular brake that prevents premature global activation and depletion of the ovarian primordial follicle pool.
Therapeutic & Clinical Pharmacology: Activating endogenous FOXO3 nuclear translocation (via dietary restriction mimetics, AMPK activators, SIRT1 activators, or PI3K/mTOR attenuation) is a central pillar of translational longevity and stem-cell rejuvenation biology.